7 cm) than BP (2.2 cm). ~h k same was found in primordial dwarfism (4 f) and Russell-Silver syndrome (3 m). It is concluded that R and T give better overall results, if bone age does not deviate more than about f 2 years from CA. In conditions with larger differences, BP is more accurate. Delayed growth and adolescence (D.c.A.) with l a c k of adrenarche : catch-up of growth with dehydroepiandrosterone s u l f a t e (DIWS) therapy.
W e have good evidence that t h e r e a r e 2 main t y p e s of DGA : i n type I growth and bone age (BA) v e l o c i t i e s u s u a l l y slow down between 6/8 y e a r s ( y ) , sometimes e a r l i e r , i n c h i l d r e n who o f t e n have s h o r t s t a t u r e ; i n type I1 t h e decrease of growth and Bi s t a r t s between 12/13 y i n g i r l s and 13/14 y i n boys.
A l a c k of adrenarche a s i n d i c a t e d by low plasma l e v e l s of dehydroepizndrosterone ( D M ) i s present i n t y p d ; normal adrenarche i s present i n type I1 a s i n hypogonadotrop h i c hypogonadism. To t e s t t h e Q p o t h e s i s that t h e l a c k of
adrenarche i s responsible f o r t h e DCL i n type I we s t u d i e d t h e e f f e c t of DILLS therapy i n a 12 y o l d g i r l with t y p i c a l type I. Except f o r c o n s i s t e n t l y low plasma l e v e l s of DIW : 10 t o 22 ng/dl, a l l endocrine f u n c t i o n s were normal. DHAS was given a s a s i n g l e o r a l morning dose of 5 mg/day f o r one y : growth v e l o c i t y increased from 3.5 t o 9 with a growth over 3 v e l o c i t i e s r a t i o = 1.3. From t h i s preliminary study we suggest t h a t a l a c k of adrenarche i s respons i b l e f o r t h e delayed maturation i n DGA type I and t h a t o r a l DIDIS could be a u s e f u l s u b s t i t u t i v e therapy.
M. RANKE* and J.R. BIERICH. 1 5 Dept. of Diagnostic Endocrinology, University, Children's Hospital, Tubingen, Germany. Comparison of circulating human growth hormone measured by radioimmunoassay (RIA) and radioreceptorassay (RRA) in plasma of children.
The binding characteristics of cultured human lymphocytes-IM9 in a plasmafree sample have been already definied (1). A modification of the original RRA method with IM-9 cells allows measurements of hGH in plasma at concentrations above 3.5 nglml (sensitivity of the RIA approx. 0.5 ng/ml) using only 0.1 ml plasma. A parallel study of hGH by RRA and RIA was carried out in 41 GH-deficient but receiving 4 I.U. of GH and 41 constitutionally short stature children duuring sleep. The results gave good agreement between RRA and RIA values (~0.79, p4.05) and showed a parallelism between the regression lines after GH administration (RRA=0.38 5 0.807 RIA) and during sleep (RRA=0.49+0.808 RIA). Single observations indicate that circulating hGH sometimes shows marked heterogeneity in respect to immunological and biological activity. E. de PERETTI, M.G. FOREST, L. DAVID, R. FRANCOIS 16 and 3 . BERTRAND, INSERM, U. 34, H z p i t a l Debrousse and Hapita1 Edouard-Herriot, Lyon, France. Dehydroepiandrosterone (DHA), i t s s u l f a t e (DHAS), 17-hydroxyprogesterone (OW) and c o r t i s o l (F) l e v e l s i n panhypopit u i t a r i s m (group I ) and i s o l a t e d GH d e f i c i e n c y (group 11) : Evidence f o r a p i t u i t a r y hormone c o n t r o l l i n g adrenal androgens b i o s y n t h e s i s .
Ten s u b j e c t s of g r o u p 1 (10-22 y e a r s ) were studied i n com-
